A new Cochrane review demonstrates that respiratory syncytial virus (RSV) vaccines are safe and effective in protecting ...

A new Cochrane review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in ...

A new Cochrane review bolsters confidence in the safety and effectiveness of RSV vaccines for older adults and pregnant ...

Context: I coauthored a published review of anticoagulation for venous thromboembolism in the Cochrane Database of Systematic Reviews and published a review on the same topic in MedGenMed (now the ...

We did not find enough good‐quality evidence to draw reliable conclusions about the benefits and risks of different work-break interventions for preventing musculoskeletal symptoms and disorders ...

The off-label use of ketamine to treat chronic pain is not supported by scientific evidence, a new Cochrane review has found The off-label use of ketamine to treat chronic pain is not supported by ...

In today's Morning Rounds newsletter, burning questions on MMR vaccines, a perimenopause business boom, and more.

SALT LAKE CITY--(BUSINESS WIRE)-- BSD Medical Corporation (NASDAQ: BSDM) today reported significant clinical results from the use of hyperthermia to treat cervical cancer. The results were presented ...

The current commentary examines the fundamental tensions between conventional evidence synthesis methods and the personalized clinical trial paradigms emerging from the remarkable scientific advances ...

Vaccines for respiratory syncytial virus (RSV) reduce the risk of infection in older adults and infants, according to a new ...

The review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in protecting groups who are most at risk for ...